Levenson Robin B, Camacho Marc A, Horn Erin, Saghir Amina, McGillicuddy Daniel, Sanchez Leon D
Department of Radiology, Division of Emergency Radiology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
Emerg Radiol. 2012 Dec;19(6):513-7. doi: 10.1007/s10140-012-1059-7. Epub 2012 Jun 29.
This study aimed to assess the effect of eliminating routine oral contrast use for abdominopelvic (AP) computed tomography (CT) on emergency department (ED) patient throughput and diagnosis. Retrospective analysis was performed on patients undergoing AP CT during 2-month periods prior to and following oral contrast protocol change in an urban, tertiary care ED. Patients with inflammatory bowel disease, prior gastrointestinal tract-altering surgery, or lean body habitus continued to receive oral contrast. Oral contrast was otherwise eliminated from the AP CT protocol. Patients were excluded if they would not have typically received oral contrast, regardless of the intervention. Data recorded include patient demographics, ED length of stay (LOS), time from order to CT, 72-h ED return, and repeat imaging. Two thousand and one ED patients (1,014 before and 987 after protocol change) underwent AP CT during the study period. Six hundred seven pre-intervention and 611 post-intervention were eligible for oral contrast and included. Of these, 95 % received oral contrast prior to the intervention and 42 % thereafter. After the intervention, mean ED LOS among oral contrast eligible patients decreased by 97 min, P < 0.001. Mean time from order to CT decreased by 66 min, P < 0.001. No patient with CT negative for acute findings had additional subsequent AP imaging within 72 h at our institution that led to a change in diagnosis. Eliminating routine oral contrast use for AP CT in the ED may be successful in decreasing LOS and time from order to CT without demonstrated compromise in acute patient diagnosis.
本研究旨在评估在腹部盆腔(AP)计算机断层扫描(CT)中取消常规口服对比剂对急诊科(ED)患者周转率和诊断的影响。对一家城市三级医疗急诊科在口服对比剂方案改变前后2个月期间接受AP CT检查的患者进行回顾性分析。患有炎症性肠病、既往有胃肠道改变手术史或体型偏瘦的患者继续接受口服对比剂。否则,从AP CT方案中取消口服对比剂。如果患者无论干预措施如何通常都不会接受口服对比剂,则将其排除。记录的数据包括患者人口统计学信息、ED住院时间(LOS)、从开单到CT检查的时间、72小时内ED复诊情况以及重复成像情况。在研究期间,2001例ED患者(方案改变前1014例,改变后987例)接受了AP CT检查。干预前607例和干预后611例符合口服对比剂条件并被纳入研究。其中,95%的患者在干预前接受了口服对比剂,干预后这一比例为42%。干预后,符合口服对比剂条件的患者平均ED LOS减少了97分钟,P<0.001。从开单到CT检查的平均时间减少了66分钟,P<0.001 在我们机构,72小时内急性检查结果为CT阴性的患者均未进行额外的后续AP成像检查,也未导致诊断改变。在ED中取消AP CT的常规口服对比剂使用可能成功减少LOS以及从开单到CT检查的时间,且不会对急性患者的诊断造成明显影响。